Skip to main content
. 2013 Aug 27;14(9):17536–17552. doi: 10.3390/ijms140917536

Figure 1.

Figure 1

Descriptive statistics of (A) interleukin 6 (IL-6); (B) interleukin 8 (IL-8); (C) vascular endothelial growth factor (VEGF); and (D) platelet derived growth factor (PDGF) levels in the groups of HCC patients and healthy controls. Circulating angiogenic factors (IL-6, IL-8, and VEGF) were significantly higher in HCC patients than the control groups. *p < 0.05; **p < 0.01.